Template-Free Synthesis of Hollow/Porous Organosilica-FeO Hybrid Nanocapsules Toward Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound Therapy
Overview
Biotechnology
Authors
Affiliations
Entirely differing from the common templating-based multistep strategy for fabricating multifunctional hollow mesoporous silica nanoparticles (HMSN), a facile and template-free synthetic strategy has been established to construct a unique hollow/mesoporous organosilica nanocapsule (OSNC) concurrently encapsulating both isopentyl acetate (PeA) liquid and superparamagnetic iron oxides inside (denoted as PeA@OSNC). This novel material exhibits ultrasmall and uniform particle size (∼82 nm), high surface area (∼534 m·g), and excellent colloidal stability in aqueous solution. The oil-phase PeA with relatively low boiling point (142 °C) and high volatility not only plays a crucial role in formation of a large hollow cavity from the viewpoint of structural design but also enables the PeA@OSNC to act as an efficient enhancement agent in high-intensity focused ultrasound (HIFU) therapy. Moreover, the unique satellite-like distribution of FeO nanoparticles (NP) on the organosilica shell offered excellent magnetic resonance imaging (MRI) contrast capability of PeA@OSNC in vitro and in vivo. More importantly, such a novel theranostic agent has favorable biosafety, which is very promising for future clinical application in MRI-guided HIFU therapy.
Song N, Chen S, Wang H, He X, Wei B, Li R Micromachines (Basel). 2024; 15(11).
PMID: 39597181 PMC: 11596985. DOI: 10.3390/mi15111369.
Nano-engineering nanomedicines with customized functions for tumor treatment applications.
Wang Y, Li S, Ren X, Yu S, Meng X J Nanobiotechnology. 2023; 21(1):250.
PMID: 37533106 PMC: 10399036. DOI: 10.1186/s12951-023-01975-3.
Insight into Potential Biomedical Application of Mesoporous Materials.
Spiridon I, Cruntu I, Spiridon I, Brescu R Pharmaceutics. 2022; 14(11).
PMID: 36365200 PMC: 9694242. DOI: 10.3390/pharmaceutics14112382.
Iron-Based Hollow Nanoplatforms for Cancer Imaging and Theranostics.
Luo S, Qin S, Oudeng G, Zhang L Nanomaterials (Basel). 2022; 12(17).
PMID: 36080059 PMC: 9457987. DOI: 10.3390/nano12173023.
Yao M, Ma M, Xu H, Pan X, Xu G, Wu R RSC Adv. 2022; 8(9):4514-4524.
PMID: 35539524 PMC: 9077886. DOI: 10.1039/c7ra12074e.